BRIEF-Adamas to present new ADS-5102 data from phase 2 trial
February 17, 2017 at 08:11 AM EST
* Adamas to present new ADS-5102 data from phase 2 trial in walking impairment associated with multiple sclerosis at actrims forum 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.